Minimum inhibitory concentrations of seven new 3-lactam derivatives were determined against 35 isolates of Yersinia enterocolitica. Ceftizoxime and ceftriaxone were the most active of the antimicrobial agents tested.
Yersinia enterocolitica infections are common in certain geographic locations (5, 9) . Gastroenteritis is the most frequent manifestation; however, terminal ileitis, septicemia, and extragastrointestinal infections also occur (3). Previous in vitro susceptibility studies of Y. enterocolitica indicated that trimethoprim-sulfamethoxazole and aminoglycosides were the most active antimicrobial agents available (1, 2, 6 
